FloraWorks

FloraWorks had the honor of presenting at the CB1, CB2 & Cannabinoid Drug Development Summit, Translating Novel Preclinical Research Into the Clinic in Boston last month. In the presentation and workshop, we explored the therapeutic potential of TruCBN™ (FloraWorks proprietary CBN-based ingredient) as a novel approach in sleep medicine. Our session, "CBN as a Candidate for Research in Sleep Medicine," provided insights into how TruCBN™ is positioned not only as an effective sleep aid but also as a future candidate for broader drug development opportunities. By targeting the CB1 and CB2 receptors in the endocannabinoid system, TruCBN™ offers significant potential for enhancing sleep quality and improving sleep onset without the psychoactive effects typical of other cannabinoids or melatonin. This may be particularly useful for consumers suffering from jet lag or other types of sleep disruption. We also moderated a lively discussion with the audience in a workshop following our presentation, where we reviewed preclinical findings, which support CBN's effects on improving sleep architecture, reducing arousal through orexin modulation, and ultimately enhancing both NREM and REM sleep. It was inspiring to engage with experts and pioneers in cannabinoid science who are pushing the boundaries of what phytocannabinoids can do for human health. As we move forward, I am optimistic about the future of cannabinoid-based therapies and the role TruCBN™ can play in providing natural, targeted solutions for sleep health. The science behind TruCBN™ is exciting, with a focus on delivering better, restorative sleep safely and effectively. Thank you to all who attended and to the organizers for making this conference such a dynamic platform for innovation. #CB1CB2Conference #TruCBN #SleepMedicine #CannabinoidScience #FloraWorks #Cannabinol #sleepscience Alleh Lindquist Micah Hogan Matthew Roberts, Ph.D., MBA Vaughn Hartung Audrey Bradshaw Sacha Webley

"Less than 1% of supplements in America have clinical evidence proving they outperform placebo.” 🌿 That’s what makes the recent feature in SupplySide Insights so meaningful—it highlights how rigorous clinical research is proving the effectiveness of cannabinoids for sleep, anxiety, and pain. At FloraWorks, we’re proud to contribute to this transformation. Our peer-reviewed study on TruCBN™ demonstrated that a 50mg dose significantly improves sleep quality, surpassing the efficacy of melatonin—all without notable side effects. This isn’t just about us—it’s about reshaping wellness with science-backed solutions that consumers can trust. Read the full story here: SupplySide Supplement Journal—New clinical data highlights benefits of cannabinoids for anxiety, sleep and pain (https://lnkd.in/gJmmmrZD) #Cannabinoids #CBN #Wellness #Science #NaturalHealth #Sleep

Least exciting post of the year! We’ve just updated our LinkedIn Page 😐 🫡 But check out our new website..... if you like cannabinoid science and minor cannabinoids..... https://lnkd.in/gP9kbZM 🔬

Had an incredible time at the Nutrition Capital Network's Fall Investor Meeting! Held on November 6-7, 2024 at the historic Golden Gate Club at the Presidio in San Francisco, this event was more than just a showcase—it was a convergence of visionaries and trailblazers in health, wellness, and nutrition. It was an honor to present FloraWorks’ groundbreaking product, TruCBN™, to a highly engaged network of investors. TruCBN™ is a clinically validated sleep aid that goes beyond melatonin, pioneering a new era in sleep health. Our research is opening doors to better sleep and advancements in neuroprotection and restorative wellness. Highlights from our presentation: ✨ Clinical validation studies show significant improvements in sleep quality ✨ Ongoing NDI certification sets the stage for a Q2 2025 mainstream launch ✨ Positioned as a trusted, natural alternative in a market lacking safe, effective solutions With FloraWorks financially sound and cash flow positive, we’re now seeking expansion capital to bring TruCBN™-based consumer products to life.  The response at NCN was overwhelmingly positive, but finding the right investors to help us reshape the sleep aid dietary ingredient space is essential—and we will continue to explore other interests. The Presidio’s breathtaking setting was a powerful reminder of what’s possible when innovation meets opportunity. Thank you to NCN and everyone who made this event unforgettable. Let’s continue redefining wellness, one breakthrough at a time.  If you’d like to learn more about TruCBN™ or FloraWorks, let’s connect! #Innovation #SleepHealth #Nutrition #Investing #FloraWorks #TruCBN

FloraWorks is at the intersection of two massive market opportunities: A $33b cannabinoid market and a $72b sleep aid market 🚀 We are thrilled to share that FloraWorks has been featured in NutraIngredients USA, a leading source of news and analysis for the global nutrition industry. Why does this matter? NutraIngredients USA is at the forefront of health and wellness trends, and being featured here underscores the growing importance of cannabinoids like TruCBN in mainstream CPG and wellness retail. TruCBN is not just another cannabinoid—it's the first clinically validated cannabinoid for sleep improvement, with promising pre-clinical results in neuroregeneration. Why does this matter to your brand? ✅ You Need Consumer Trust: 92% of consumers seek products with clinical validation because they trust scientific proof over mere advertising claims. ✅ You Want Expanded Sales Channels: Major retailers now require safety and efficacy studies, opening shelf space only for supplements with scientifically backed claims. ✅ You Require Validated Marketing Claims: FDA and FTC oversight requires transparent claims supported by validated clinical research. As more consumers demand natural, science-backed wellness solutions, TruCBN is positioned to bridge the gap between the more fringe cannabinoid products and the broader mainstream wellness market. We’re excited to lead the charge in bringing effective, natural solutions to consumers everywhere. Let’s connect to explore how TruCBN can enhance your product offerings and drive innovation in the wellness space. https://lnkd.in/ezmGxvwi #NutraIngredientsUSA #TruCBN #WellnessInnovation #CPG #NaturalProducts #Cannabinoids #RetailInnovation https://lnkd.in/eQ7YNd-4

Want to know more about the future of cannabis CPG? Check out the latest episode of The Dales Report, where our VP of Sales and Marketing Micah Hogan discusses the role minor cannabinoids have on edible products and industry trends! #CBN #TruCBN #THC #Cannabis #Hemp #CBG #CBC #THCv #Trends

Shaping the Future of Cannabinoid Science: TruCBN™ Sets a New Standard 🌿 FloraWorks is proud to announce a monumental leap in cannabinoid therapeutic development—TruCBN™ is now the first cannabinoid proven to be a safe and effective sleep aid, validated by the largest blinded, randomized, placebo-controlled clinical trial ever conducted on a single cannabinoid. 🥇 This landmark research, published in the peer-reviewed journal Pharmaceuticals (MDPI), is set to redefine the future of sleep science and cannabinoid applications. 📈 Impacting the Future: This groundbreaking study is the first to clinically validate the sleep-enhancing benefits of a cannabinoid, transforming anecdotal claims into scientifically backed evidence. TruCBN™ is not just another supplement; it represents a significant advancement in the search for natural, safe, and effective sleep solutions. 🌙 Key Milestones: - TruCBN™ (50mg) significantly improved sleep quality compared to a placebo. Outperformed melatonin in promoting better sleep. - No significant side effects compared to the placebo, reinforcing its safety. As the demand for effective sleep solutions grows, TruCBN™ is poised to meet the need, offering a scientifically validated alternative to traditional sleep aids. "This publication is a testament to our commitment to advancing scientific understanding and clinical validation of cannabinoids. It's a major step in bringing TruCBN™ into mainstream markets as a safe and effective alternative in the fight against sleeplessness." - Alleh Lindquist, CEO of FloraWorks Stay tuned as we continue to pioneer the future of wellness through cannabinoid research and development. 🌿 #CannabinoidScience #TruCBN #SleepHealth #Innovation #FloraWorks #CBN #ClinicalResearch #WellnessRevolution #NaturalSleepAid #ScientificBreakthrough https://lnkd.in/gv4mcXGq

CBN sales are on a 🚀 trajectory! Do you want to know what the next wave of cannabinoid sleep aid products is going to look like....? Find out here ---> https://lnkd.in/ezmGxvwi

"Can consumer trust in cannabinoids reshape the wellness industry?" Listen to FloraWorks CEO Alleh Lindquist on The Dime podcast for insights. 🌿🧬 At FloraWorks, we’re proving the potential of cannabinoids through rigorous research and innovation. Our CEO, Alleh Lindquist, shares exciting developments on The Dime podcast, highlighting our role in reshaping the wellness industry. Key Highlights: 1. Breakthrough CBN Research: We've patented a process for TruCBN™, demonstrating its effectiveness in improving sleep quality and duration through double-blind placebo-controlled studies. 2. TruCBN™ vs. Melatonin: Our research revealed that 50mg of TruCBN™, not only show significant improvement over placebo but also outperformed the standard dose of melatonin. This positions TruCBN™ as a great candidate to replace melatonin for consumers seeking a natural sleep solutions. 3. CBN vs. CBD for Sleep: Unlike CBD, which faces regulatory hurdles due to its classification as an epilepsy drug (Epidiolex), CBN offers a clear path forward. TruCBN™ meets FDA standards, making it a more viable option for developing trusted sleep aids. 4. Building Consumer Trust: By focusing on scientific validation, we’re building consumer confidence. Our partnerships with industry leaders like Grön and Wyld underscore the market’s trust in our solutions. 5. Expanding Applications: We’re exploring cannabinoids' broader potential, collaborating with the Salk Institute and the National Cancer Institute on neuroprotection and cancer treatment. Why This Matters to Our B2B Partners: Transformative Products: Offer scientifically validated health benefits with TruCBN™. Regulatory Compliance: Partnering with FloraWorks ensures compliance with rigorous standards. Market Differentiation: Stand out with innovative, clinically validated marketing claims. Consumer Confidence: Build trust with products backed by solid scientific research. Join the Revolution: Tune in to The Dime podcast to hear more from Alleh Lindquist on how FloraWorks is transforming health and wellness with cannabinoids. Listen now: Can CBN Replace Melatonin? 🎧 #CannabinoidScience #Innovation #HealthRevolution #FloraWorks #TrueCBN https://lnkd.in/eWjsH6K5

📢 **News from FloraWorks!** 🌿 We are thrilled to announce the appointment of Matthew Roberts, Ph.D., MBA as our new Chief Operating Officer. With over 25 years of experience in the health and wellness sectors, Dr. Roberts brings a wealth of knowledge and expertise to our team. His impressive background with industry leaders such as Pharmavite, The Nature's Bounty Co. , Abbott Nutrition NL, and Nestlé positions him perfectly to drive FloraWorks' next phase of growth and innovation. As we enter into the nutraceutical cannabinoid ingredient space with TruCBN, our clinically validated CBN isolate, we are poised to revolutionize how people experience cannabinoids. With Dr. Roberts' leadership, we are confident that FloraWorks will elevate TruCBN to new heights, ensuring its success and mainstream adoption. Matthew Roberts, Ph.D., MBA welcome to the FloraWorks team! We look forward to his strategic insights and operational excellence propelling our mission to advance cannabinoid therapeutics. #FloraWorks #Leadership #CannabinoidTherapeutics #TruCBN #Innovation #Growth #HealthAndWellness https://lnkd.in/ekWBurYE